The new variant of Creutzfeldt-Jakob disease

OIE Revue Scientifique et Technique

Volumn 12, Issue 1, 2000, Pages 98-120

  Zeidler, M ^a   Ironside, J W ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Bovine spongiform encephalopathy; Creutzfeldt Jakob disease; New variant Creutzfeldt Jakob disease; Prion disease; Transmissible spongiform encephalopathies; United Kingdom

Indexed keywords

BOVINAE;

ANIMAL; BOVINE SPONGIFORM ENCEPHALOPATHY; CATTLE; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; HUMAN; PHYSIOLOGY; PRION; REVIEW; RISK FACTOR; UNITED KINGDOM; ZOONOSIS;

ANIMALS; CATTLE; CREUTZFELDT-JAKOB SYNDROME; ENCEPHALOPATHY, BOVINE SPONGIFORM; GREAT BRITAIN; HUMANS; PRIONS; RISK FACTORS; ZOONOSES;

EID: 0034173484     PISSN: 02531933     EISSN: None     Source Type: Journal    
DOI: 10.20506/rst.19.1.1206     Document Type: Article

References (107)

1. Alperovitch A., Zerr I., Pocchiari M., Mitrova E., de Pedro Cuesta J., Hegyi I., Collins S., Kretzschmar H., van Duijn C. & Will R.G. (1999). - Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet, 353, 1673-1674.
2. Anderson R.M., Donnelly C.A., Ferguson N.M., Woolhouse M.E., Watt C.J., Udy H.J., Mawhinney S., Dunstan S.P., Southwood T.R., Wilesmith J.W., Ryan J.B., Hoinville L.J., Hillerton J.E., Austin A.R. & Wells G.A. (1996). - Transmission dynamics and epidemiology of BSE in British cattle. Nature, 382, 779-788.
3. Baker H.F., Ridley R.M., Wells G.A. & Ironside J.W. (1998). - Prion protein immunohistochemical staining in the brains of monkeys with transmissible spongiform encephalopathy. Neuropathol. appl. Neurobiol., 24, 476-486.
4. Bastian F.O. (1991). - Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Mosby Year Book, St Louis, 256 pp.
5. Bateman D., Hilton D., Love S., Zeidler M., Beck J. & Collinge J. (1995). - Sporadic Creutzfeldt-Jakob disease in a 18-year-old in the UK. Lancet, 346, 1155-1156.
6. Bell J.E. & Ironside J.W. (1993). - Neuropathology of spongiform encephalopathies in humans. Br. med. Bull., 49, 738-777.
7. Bell J.E., Gentleman S.M., Ironside J.W., McCardle L., Lantos P.L., Doey L., Lowe J., Fergusson J., Luthert P., McQuaid S. & Allen I.V. (1997). - Prion protein immunocytochemistry - UK five centre consensus report. Neuropathol. appl. Neurobiol., 23, 26-35.
8. Bons N., Mestre-Frances N., Belli P., Cathala F., Gajdusek D.C. & Brown P. (1999). - Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Prac. natl Acad. Sci. USA, 96, 4046-4051.
9. Bradley R. & Matthews D. (eds) (1992). - Transmissible spongiform encephalopathies of animals. Rev. sci. tech. Off. int. Epiz., 11 (2), 304 pp.
10. Britton T.C., Al-Sarraj S., Shaw C., Campbell T. & Collinge J. (1995). - Sporadic Creutzfeldt-Jakob disease in a 16-year-old in the UK. Lancet, 346, 1155.
11. Brown D.R. & Besinger A. (1998). - Prion protein expression and superoxide dismutase activity. Biochem. J., 334, 423-429.
12. Brown P. (1996). -Environmental causes of human spongiform encephalopathy. In Prion diseases (H.F. Baker & R.M. Ridley, eds). Humana Press, Totowa, New Jersey, 139-154.
13. Brown P., Cathala F., Castaigne P. & Gajdusek D.C. (1986). - Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann. Neurol., 20, 597-602.
14. Brown P., Gibbs C.J. Jr, Rodgers-Johnson P., Asher D.M., Sulima M.P., Bacote A., Goldfarb L.G. & Gajdusek D.C. (1994). - Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann. Neurol., 35, 513-529.
15. Bruce M.E. (1993). - Scrapie strain variation and mutation. Br. med. Bull., 49, 822-838.
16. Bruce M.E., Chree A., McConnell I., Foster J., Pearson G. & Fraser H. (1994). - Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Proc. roy. Soc. Lond., B, biol Sci., 343, 405-411.
17. Bruce M.E., Will R.G., Ironside J.W., McConnell I., Drummond D., Suttie A., McCardle L., Chree A., Hope J., Birkett C., Cousens S., Fraser H. & Bostock C.J. (1997). -Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature, 389, 498-501.
18. Budka H. (1998). - Fatal familial insomnia around the world. Brain Pathol., 8, 553-570.
19. Budka H., Aguzzi A., Brown P., Brucher J.M., Bugiani O., Collinge J., Diringer H., Gullotta F., Haltia M., Hauw J.J., Ironside J.W., Kretzschmar H.A., Lantos P.L., Masullo C., Pocchiari M., Schlote W., Tateishi J. & Will R.G. (1996). -Consensus report: tissue handling in suspected Creutzfeldt-Jakob disease and other spongiform encephalopathies (prion diseases) in the human. European Union Biomed-1 Concerted Action. Pathology, 17, 171-175.
20. Chazot G., Broussolle F., Lapras C.I., Blattler T., Aguzzi A. & Kopp N. (1996). - New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet, 347, 181.
21. Collinge J., Sidle K.C., Meads J., Ironside J. & Hill A.F. (1996). - Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature, 383, 685-690.
22. Cousens S.N., Vynnycky E., Zeidler M., Will R.G. & Smith P.G. (1997). - Predicting the CJD epidemic in humans. Nature, 385, 197-198.
23. Cousens S.N., Zeidler M., Esmonde T.F., de Silva R., Wilesmith J.W., Smith P.C. & Will R.G. (1997). - Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96. BMJ, 315, 389-395.
24. Cousens S.N., Linsell E., Smith P.G., Chandrakumar M., Wilesmith J.W., Knight R.S., Zeidler M., Stewart G. & Will R.G. (1999). - Geographical distribution of variant CJD in the UK (excluding Northern Ireland). Lancet, 353, 18-21.
25. Creutzfeldt H.G. (1920). - Über eine eigenartige herdförmige Erkrankung des Zentralnervensystems [On a particular focal disease of the central nervous system]. Zeitschr. Gesamte Neurol. Psychiatr., 57, 1-18.
26. Cuillé J. & Chelle P.L. (1939). - Experimental transmission of scrapie to the goat. C.R. Acad. Sci. (Paris), 208, 1058-1060.
27. De Silva R., Patterson J., Hadley D., Russell A., Turner M. & Zeidler M. (1998). - Single photon emission computed tomography in the identification of new variant Creutzfeldt-Jakob disease: case reports. BMJ, 316, 593-594.
28. Deslys J.P., Jaegly A., d'Aignaux J.H., Mouthon F., de Villemeur T.B. & Dormont D. (1998). - Genotype at codon 129 and susceptibility to Creutzfeldt-Jakob disease. Lancet, 351, 1251.
29. Duffy P., Wolf J., Collins G., DeVoe A.C., Streeten B. & Cowen D. (1974). - Possible person-to-person transmission of Creutzfeldt-Jakob disease. New Engl. J. Med., 290, 692-693.
30. Farquhar C., Dickinson A. & Bruce M. (1999). -Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies. Lancet, 353, 117.
31. Finkenstaedt M., Szudra A., Zerr I., Poser S., Hise J.H., Stoebner J.M. & Weber T. (1996). - MR imaging of Creutzfeldt-Jakob disease. Radiology, 199, 793-798.
32. Franklin I.M. (1999). - The impact on British blood services of BSE and v-CJD: implications for patients, donors and public health. Scottish med. J., 44, 35-36.
33. Fraser H. (1979). - The pathogenesis and pathology of scrapie. In Aspects of slow and persistent virus infections (D.A.J. Tyrrell, ed.). Martinus Nijhoff, The Hague, 30-58.
34. Gajdusek D.C. (1967). - Slow-virus infections of the nervous system. New Engl. J. Med., 276, 392-400.
35. Gajdusek D.C. (1977). - Unconventional viruses and the origin and the disappearance of kuru. Science, 197, 943-960.
36. Gajdusek D.C., Gibbs C.J. Jr & Alpers M.P. (1966). -Experimental transmission of a kuru-like syndrome to chimpanzees. Nature, 209, 794-796.
37. Galvez S. & Cartier L. (1984). - Computed tomography findings in 15 cases of Creutzfeldt-Jakob disease with histological verification. J. Neurol. Neurosurg. Psychiatry, 47, 1244-1246.
38. Garcia Santos J.M., Lopez Corbalan J.A., Martinez-Lage J.F. & Sicilia Guillen J. (1996). - CT and MRI in iatrogenic and sporadic Creutzfeldt-Jakob disease: as far as imaging perceives. Neuroradiology, 38, 226-231.
39. Ghani A.C., Ferguson N.M., Donnelly C.A., Hagenaars T.J. & Anderson R.M. (1998). - Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain. Proc. roy. Soc. Lond., B, biol. Sci., 265, 2443-2452.
40. Gibbs C.J. Jr, Gajdusek D.C., Asher D.M., Alpers M.P., Beck E., Daniel P.M. & Matthews W.B. (1968). -Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science, 161, 388-389.
41. Gibbs C.J. Jr, Masters C.L. & Gajdusek D.C. (1979). -Bibliography of Creutzfeldt-Jakob disease. Government Printing Office, Washington, DC, 169 pp.
42. Classe R. (1967). - Cannibalism in the Kuru region of New Guinea. Trans. NT. Acad. Sci., 29, 748-754.
43. Goldmann W., Hunter N., Smith G., Foster J. & Hope J. (1994). - PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie. J. gen. Virol., 75, 989-995.
44. Gore S.M. (1995). - More than happenstance: Creutzfeldt-Jakob disease in farmers and young adults. BMJ, 511, 1416-1418.
45. Gore S.M., Bingham S. & Day N.E. (1997). - Age related dietary exposure to meat products from British dietary surveys of teenagers and adults in the 1980s and 1990s. BMJ, 315, 404-405.
46. Green A.J.E., Thompson E.J., Zeidler M., Stewart G.E., Mackenzie J.M., Macleod M.A., Knight R.G. & Will R.G. (2000). - Raised concentrations of brain specific proteins in patients with sporadic and new variant CJD. J. Neurol. Neurosurg. Psychiatry (in press).
47. Hadlow W.J. (1959). - Scrapie and Kuru. Lancet, 2, 289-290.
48. Hill A.F., Desbruslais M., Joiner S., Sidle K.C., Gowland I., Collinge J., Doey L.J. & Lantos P. (1997). -The same prion strain causes vCJD and BSE. Nature, 389, 448-450.
49. Hill A.F., Will R.G., Ironside J. & Collinge J. (1997). - Type of prion protein in UK farmers with Creutzfeldt-Jakob disease. Lancet, 350, 188.
50. Hill A.F., Zeidler M., Ironside J. & Collinge J. (1997). -Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet, 349, 99-100.
51. Hill A.F., Butterworth R.J., Joiner S., Jackson G., Rossor M.N., Thomas D.J., Frosh A., Tolley N., Bell J.E., Spencer M., King A., Al-Sarraj S., Ironside J.W., Lantos P.L. & Collinge J. (1999). - Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet, 353, 183-189.
52. Hilton D.A., Fathers E., Edwards P., Ironside J.W. & Zajicek J. (1998). - Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet, 352, 703-704.
53. Hope J. (1994). - The nature of the scrapie agent: the evolution of the virino. Ann. N. Y. Acad. Sci., 724, 282-289.
54. Howard R. (1996). - Creutzfeldt-Jakob disease in a young woman. Lancet, 347, 945-948.
55. Hsich G., Kenney K., Gibbs C.J. Jr, Lee K.H. & Harrington M.G. (1996). - The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. New Engl. J. Med., 335, 924-930.
56. Ironside J.W. (1998). - New-variant Creutzfeldt-Jakob disease. Neuropathology, 18, 131-138.
57. Ironside J.W. & Bell J.E. (1996). - The 'high-risk' neuropathological autopsy in AIDS and Creutzfeldt-Jakob disease: principles and practice. Neuropathol. appl. Neurobiol., 22, 388-393.
58. Ironside J.W., Sutherland K., Bell J.E., McCardle L., Barrie C., Estebeiro K., Zeidler M. & Will R.G. (1996). - A new variant of Creutzfeldt-Jakob disease: neuropathological and clinical features. Cold Spring Harb. Symp. quant. Biol., 61, 523-530.
59. Ironside J.W., Knight R.S., Will R.G., Smith P.G. & Cousens S.N. (1998). - New variant Creutzfeldt-Jakob disease is more common in Britain than elsewhere. BMJ, 317, 352.
60. Jakob A. (1921). - Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenwertem anatomischen Befund (spastische Pseudosclerose-Encephalomyelopathie mit disseminierten Degenerationsherden) [Concerning peculiar disorders of the central nervous system with remarkable anatomical findings (spastic pseudosclerosis-encephalopathy with disseminated foci of degeneration)]. Dtsch. Zeitschr. Nenenheilkd., 70, 132-146.
61. Jakob A. (1921). - Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenwertem anatomischen Befund (spastische Pseudosclerose-Encephalomyelopathie mit disseminierten Degenerationsherden). Zeitschr. Gesamte Neurol. Psychiatr., 64, 147-228.
62. Jakob A. (1921). - Über eine der multiplen Sklerose klinisch nahestehende Erkrankung des Zentralnervensystems (spastische Pseudosklerose) mil bemerkenswertem anatomischen Befunde [Concerning a disorder of the central nervous system clinically resembling multiple sclerosis with remarkable anatomical findings (spastic pseudosclerosis)]. Mitteilung eines vierten Falles. Med. Klin., 17, 372-376.
63. Kawashima T., Furukawa H., Doh-ura K. & Iwaki T. (1997). - Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet, 350, 68-69.
64. Kellings K., Meyer N., Mirenda C., Prusiner S.B. & Riesner D. (1993). - Analysis of nucleic acids in purified scrapie prion preparations. Arch. Virol. Suppl., 7, 215-225.
65. Kitamoto T., Amano N., Terao Y., Nakazato Y., Isshiki T., Mizutani T. & Tateishi J. (1993). - A new inherited prion disease (PrP-P105L mutation) showing spastic paraparesis. Ann. Neurol., 34, 808-813.
66. Klein M.A., Frigg R., Flechsig E., Raeber A.J., Kalinke U., Bluethmann H., Bootz F., Suter M., Zinkernagel R.M. & Aguzzi A. (1997). - A crucial role for B cells in neuroinvasive scrapie. Nature, 390, 687-690.
67. Klein M.A., Frigg R., Raeber A.J., Flechsig E., Hegyi I., Zinkernagel R.M., Weissmann C. & Aguzzi A. (1998). - PrP expression in B lymphocytes is not required for prion neuroinvasion. Nat. Med., 4, 1429-1433.
68. Lasmezas C.I., Deslys J.P., Demalmay R., Adjou K.T., Lamoury F., Dormont D., Robain O., Ironside J. & Hauw J.J. (1996). - BSE transmission to macaques. Nature, 381, 743-744.
69. Liberski P.P. & Gajdusek D.C. (1997). - Kuru: forty years later, a historical note. Brain Pathol., 7, 555-560.
70. Masters C.L. & Richardson E.P. Jr (1978). - Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain, 101, 333-344.
71. Masters C.L., Harris J.O., Gajdusek D.C., Gibbs C.J. Jr, Bernoulli C. & Asher D.M. (1979). - Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann. Neurol., 5, 177-188.
72. Masters C.L.A., Gajdusek D.N.C., Smith W.T. & Cavanagh J.B. (1982). - Recent advances in neuropathology. Churchill Livingstone, Edinburgh, 139-163.
73. National United Kingdom (UK) Creutzfeldt-Jakob Disease (CJD) Surveillance Unit (1998). - Creutzfeldt-Jakob disease surveillance in the United Kingdom: Seventh Annual Report. National UK CJD Surveillance Unit, Edinburgh, 79 pp.
74. Parchi P., Castellani R., Cortelli P., Montagna P., Chen S.G., Petersen R.B., Manetto V., Vnencak-Jones C.L., McLean M.J., Sheller J.R., Lugaresi E., Autilio-Gambetti L. & Gambetti P. (1995). - Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann. Neurol., 38 (1), 21-29.
75. Parchi P., Castellani R., Capellan S., Ghetti B., Young K., Chen S.G., Farlow M., Dickson D.W., Sima A.A., Trojanowski J.Q., Petersen R.B. & Gambetti P. (1996). -Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann. Neurol., 39, 767-778.
76. Parchi P., Giese A., Capellari S., Brown P., Schulz-Schaeffer W., Windl O., Zerr I., Budka H., Kopp N., Piccardo P., Poser S., Rojiani A., Streichenberger N., Julien J., Vital C., Ghetti B., Gambetti P. & Kretzschmar H. (1999). -Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol., 46, 224-233.
77. Piccardo P., Dlouhy S.R., Lievens P.M., Young K., Bird T.D., Nochlin D., Dickson D.W., Vinters H.V., Zimmerman T.R., Mackenzie I.R., Kish S.J., Ang L.C., De Carli C., Pocchiari M., Brown P., Gibbs C.J. Jr, Gajdusek D.C., Bugiani O., Ironside J., Tagliavini F. & Ghetti B. (1998). -Phenotypic variability of Gerstmann-Straussler-Schemker disease is associated with prion protein heterogeneity. J. Neuropathol experim. Neurol., 57 (10), 979-988.
78. Prusiner S.B. (1982). - Novel proteinaceous infectious particles cause scrapie. Science, 216, 136-144.
79. Prusiner S.B. (1998). - Prions. Proc. natl Acad. Sci. USA, 95, 13363-13383.
80. Prusiner S.B. & Hsiao K.K. (1994). - Human prion diseases. Ann. Neurol., 35, 385-395.
81. Raymond G.J., Hope J., Kocisko D.A., Pnola S.A., Raymond L.D., Bossers A., Ironside J., Will R.G., Chen S.G., Petersen R.B., Gambetti P., Rubenstein R., Smits M.A., Lansbury P.T. Jr & Caughey B. (1997). - Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature, 388, 285-288.
82. Ricketts M.N., Cashman N.R., Stratton E.E. & El Saadany S. (1997). - Is Creutzfeldt-Jakob disease transmitted in blood? Emerg. infect. Dis., 3 (2), 155-163.
83. Samaia H.B., De Jesus Mari J., Vallada H.P., Moura R.P., Simpson A.J.G. & Brentam R.R. (1997). - A prion-linked psychiatric disorder. Nature, 390, 241.
84. Schatzl H.M., Wopfner F., Gilch S., von Brunn A. & Jager G. (1997). - Is codon 129 of prion protein polymorphic in human beings but not in animals? Lancet, 349, 1603-1604.
85. Schreuder B.E.C., van Keulen L.J.M., Vromans M.E.W., Langeveld J.P.M. & Smits M.A. (1996). - Preclinical test for prion disease. Nature, 381, 563.
86. Spielmeyer W. (1922). - Die histopathologische Forschung in der Psychiatrie [Histopathological research in psychiatry]. Klin. Wochenschr.,2, 1817-1819.
87. Telling G.G., Scott M., Mastrianni J., Gabizon R., Torchia M., Cohen F.E., DeArmond S.J. & Prusiner S.B. (1995). - Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell, 83, 79-90.
88. Thomas P. & Newby M. (1999). - Estimating the size of the outbreak of new-variant CJD. Br. Food J., 101, 44-58.
89. Turner M.L. & Ironside J.W. (1998). - New-variant Creutzfeldt-Jakob disease: the risk of transmission by blood transfusion. Blood. Rev., 12, 255-268.
90. Van Duijn C.M., Delasnene-Laupretre N., Zerr I., Masullo C., de Silva R.N., Wientjens D.P.W.M., Brandel J.P., Weber T., Almonti S., Zeidler M., Alperovitch A., Poser S., Granieri E., Hofman A. & Will R.G. (1997). -Creutzfeldt-Jakob disease in Europe 1993-1995 case-control study of risk factors. Lancet, 351, 1081-1085.
91. Wientjens D.P., Davanipour Z., Hofman A., Kondo K., Matthews W.B., Will R.G. & van Duijn C.M. (1996). - Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies. Neurology, 46 (5), 1287-1291.
92. Will R.G. & Matthews W.B. (1984). - A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. 1: clinical features. J. Neurol. Neurosurg. Psychiatry, 47, 134-140.
93. Will R.G., Ironside J.W., Hornlimann B. & Zeidler M. (1996). - Creutzfeldt-Jakob disease. Lancet, 347, 65-66.
94. Will R.G., Ironside J.W., Zeidler M., Cousens S.N., Estibeiro K., Alperovitch A., Poser S., Pocchian M., Hofman A. & Smith P.G. (1996). - A new variant of Creutzfeldt-Jakob disease in the UK. Lancet, 347, 921-925.
95. Will R.G., Stewart G., Zeidler M., Macleod M.A. & Knight R.S.G. (1999). - Psychiatric features of new variant Creutzfeldt-Jakob disease. Psychiatr. Bull., 23, 264-267.
96. Will R.G., Zeidler M., Stewart G., Macleod M.A., Ironside J.W., Cousens S., Mackenzie J. & Knight R.S.G. (2000). - Developments in the diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol. (in press).
97. Williams E.S. & Young S. (1993). - Neuropathology of chronic wasting disease of mule deer (Odocoileus hemionus) and elk (Cervus elaphus nelsoni). Vet. Pathol., 30, 36-45.
98. World Health Organization (WHO) (1996). - Report of a WHO consultation on clinical and neuropathological characteristics of the new variant of CJD and other human and animal transmissible sporigiform encephalopathies, 14-16 May, Geneva. With participation of the OIE. Document No. WHO/EMC/ZOO/ 96.1. WHO, Geneva, 19 pp.
99. World Health Organization (WHO) (1996). - Report of a WHO consultation on public health issues related to human and animal transmissible spongiform encephalopathies, 2-3 April, Geneva. With the participation of the FAO and OIE. Document No. WHO/EMC/D1S/96.147. WHO, Geneva, 9 pp.
100. World Health Organization (WHO) (1997). - Report of a WHO consultation on medicinal and other products in relation to human and animal transmissible spongiform encephalopathies, 24-26 March, Geneva. With the participation of the OIE. Document No. WHO/EMC/ZOO.97.3. WHO, Geneva, 17 pp.
101. World Health Organization (WHO) (1998). - Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO Consultation, 9-11 February, Geneva. Document No. WHO/EMC/ZDI/98.9. WHO, Geneva, 30 pp.
102. Zeidler M., Johnstone E.G., Bamber R.W., Dickens C.M., Fisher C.J., Francis A.F., Goldbeck R., Higgo R., Johnson-Sabine E.C., Lodge G.J., McGarry P., Mitchell S., Tarlo L., Turner M., Ryley P. & Will R.G. (1997). - New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet, 350, 908-910.
103. Zeidler M., Stewart G., Cousens S.N., Estibeiro K. & Will R.G. (1997). - Codon 129 genotype and new variant CJD. Lancet, 350 (9078), 668.
104. Zeidler M., Stewart G.E., Barraclough C.R., Bateman D.E., Bates D., Burn D.J., Colchester A.C., Durward W., Fletcher N.A., Hawkins S.A., Mackenzie J.M. & Will R.G. (1997). - New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet, 350, 903-907.
105. Zeidler M., Knight R., Stewart G., Ironside J.W., Will R.G., Green A.J. & Pocchiari M. (1999). - Diagnosis of Creutzfeldt-Jakob disease. Routine tonsil biopsy for diagnosis of new variant Creutzfeldt-Jakob disease is not justified. BMJ, 318, 538.
106. Zeidler M., Sellar R.J., Collie D.A., Knight R.S.G., Stewart G., Macleod M.A., Ironside J.W., Cousens S.N., Hadley D., Colchester A.C. & Will R.G. (2000). - The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet (in press).
107. Zerr I., Bodemer M., Gefeller O., Otto M., Poser S., Wiltfang J., Windl O., Kretzschmar H.A. & Weber T. (1998). -Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann. Neurol., 43, 32-40.